Prosecution Insights
Last updated: August 14, 2026

The UAB Research Foundation

10 pending office actions • 8 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days

Portfolio Summary

10
Total Pending OAs
6
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (40%)
5
Medium (50%)
1
Easy (10%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (10%)
§103 only5 (50%)
Double-patenting only1 (10%)
Multi-statute (no §101)3 (30%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
60% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
20% of docket
2
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WINAKUR, ERIC FRANK 1 79.2% +13.8%
HAMA, JOANNE 1 25.1% +38.8%
LUK, EMMANUEL S 1 71.3% +26.4%
KWON, YONG SOK 1 24.6% +42.7%
SISON, CHRISTINE ANDREA PAN 1 31.9% +47.3%
ALLEN, SARAH ELIZABETH 1 60.9% +45.0%
RAUBENSTRAW, TYLER ALLEN 1 71.1% +30.7%
PARK, HAEJIN S 1 55.1% +38.5%
COOK, LISA V 1 67.3% +10.0%
RAMADAN, OMAR 1 24.2% +59.8%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17471513 METHODS FOR CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS RAMADAN, OMAR 37d overdue
18867687 DEVICES AND METHODS FOR TRANSCUTANEOUS BILIRUBIN MEASUREMENT WINAKUR, ERIC FRANK
18865259 METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING INFLAMMATORY SKIN DISORDERS HAMA, JOANNE
18667950 GENERATION OF S-NITROSOACETYLCYSTEINE KWON, YONG SOK
18022230 GENERATION OF NITRIC OXIDE AND DELIVERY SYSTEMS RAUBENSTRAW, TYLER ALLEN

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17765926 MULTI-LAYERED NANOPARTICLE COATED SUBSTRATES FOR DRUG DELIVERY PARK, HAEJIN S 162d overdue
18337705 SELECTIVE STIMULATION OF GROUPS OF NEURAL ELEMENTS WITHIN A REGION OF THE BRAIN SISON, CHRISTINE ANDREA PAN 60d overdue
17471513 METHODS FOR CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS RAMADAN, OMAR 37d overdue
18906524 ALTERNATING FIELD ELECTRODE SYSTEM AND METHOD FOR FIBER GENERATION LUK, EMMANUEL S 31d overdue
18315677 PRE-CLINICAL MODIFIED RNA APPROACHES USED IN LARGE ANIMALS FOR MUSCLE AND VASCULAR REGENERATION ALLEN, SARAH ELIZABETH 16d overdue
18867687 DEVICES AND METHODS FOR TRANSCUTANEOUS BILIRUBIN MEASUREMENT WINAKUR, ERIC FRANK
18865259 METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING INFLAMMATORY SKIN DISORDERS HAMA, JOANNE
18667950 GENERATION OF S-NITROSOACETYLCYSTEINE KWON, YONG SOK

Top Art Units

Art UnitApps
1645 1
1744 1
3796 1
1637 1
3785 1
1614 1
1642 1
1678 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18867687 DEVICES AND METHODS FOR TRANSCUTANEOUS BILIRUBIN MEASUREMENT WINAKUR, ERIC FRANK §102§103§112 Non-Final OA Pending Nov 20, 2024
18865259 METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING INFLAMMATORY SKIN DISORDERS HAMA, JOANNE 1645 §103 Non-Final OA Pending Nov 12, 2024
18906524 ALTERNATING FIELD ELECTRODE SYSTEM AND METHOD FOR FIBER GENERATION LUK, EMMANUEL S 1744 DP Final Rejection 31d overdue Pending Oct 04, 2024
18667950 GENERATION OF S-NITROSOACETYLCYSTEINE KWON, YONG SOK §102§103§112 Non-Final OA Pending May 17, 2024
18337705 SELECTIVE STIMULATION OF GROUPS OF NEURAL ELEMENTS WITHIN A REGION OF THE BRAIN SISON, CHRISTINE ANDREA PAN 3796 §103 Final Rejection 60d overdue Pending Jun 20, 2023
18315677 PRE-CLINICAL MODIFIED RNA APPROACHES USED IN LARGE ANIMALS FOR MUSCLE AND VASCULAR REGENERATION ALLEN, SARAH ELIZABETH 1637 §103 Final Rejection 16d overdue Pending May 11, 2023
18022230 GENERATION OF NITRIC OXIDE AND DELIVERY SYSTEMS RAUBENSTRAW, TYLER ALLEN 3785 §103§112 Non-Final OA Pending Feb 20, 2023
17765926 MULTI-LAYERED NANOPARTICLE COATED SUBSTRATES FOR DRUG DELIVERY PARK, HAEJIN S 1614 §103 Final Rejection 162d overdue Pending Apr 01, 2022
17479453 METHOD FOR INCREASING CELL SUSCEPTIBILITY TO COMPLEMENT- MEDIATED LYSIS COOK, LISA V 1642 §103 Non-Final OA Pending Sep 20, 2021
17471513 METHODS FOR CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS RAMADAN, OMAR 1678 §101 Non-Final OA 37d overdue Pending Sep 10, 2021

Managing The UAB Research Foundation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month